Abstract
Background
The Achilles tendon is the strongest tendon in the human body. The incidence of Achilles tendon ruptures appears to be increasing.
Objectives
The aim of this review was to systematically summarize predictors influencing Achilles tendon rupture (ATR) risk.
Methods
A systematic literature search was performed of reported determinants influencing the ATR risk. Studies were eligible if there was: (i) description of determinants predicting ATR; (ii) an outcome defined as ATR; (iii) any study design with at least ten adults included with ATR; (iv) use of statistical tests regarding differences between patients with an ATR and healthy controls; (v) a full text article available; (vi) an article written in English, German or Dutch. Quality assessment was done using a standardized criteria set. Best-evidence synthesis was performed.
Results
We included 31 studies, of which two (6.5 %) were considered high-quality studies. Moderate evidence was found for increased ATR risk and decreased fibril size of Achilles tendon.
Conclusion
Based on the results of this systematic review there is moderate evidence that decreased tendon fibril size increases the ATR risk. There is limited evidence for many other factors, some of which are modifiable, such as increased body weight, oral corticosteroid use and quinolone use and living in an urban area, and therefore may be of interest in future studies. Furthermore, these results showed that more high-quality studies are needed for evaluating the determinants influencing the ATR risk.
Similar content being viewed by others
References
Jarvinen TAH, Kannus P, Maffulli N, Khan KM. Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin. 2005;10(2):255–66.
Leppilahti J, Puranen J, Orava S. Incidence of Achilles tendon rupture. Acta Orthop Scand. 1996;67(3):277–9.
Maffulli N, Waterston SW, Squair J, Reaper J, Douglas AS. Changing incidence of Achilles tendon rupture in Scotland: a 15-year study. Clin J Sport Med. 1999;9(3):157–60.
Houshian S, Tscherning T, Riegels-Nielsen P. The epidemiology of Achilles tendon rupture in a Danish county. Injury. 1998;29(9):651–4.
Levi N. The incidence of Achilles tendon rupture in Copenhagen. Injury. 1997;28(4):311–3.
Suchak AA, Bostick G, Reid D, Blitz S, Jomha N. The incidence of Achilles tendon ruptures in Edmonton, Canada. Foot Ankle Int. 2005;26(11):932–6.
Nyyssonen T, Luthje P, Kroger H. The increasing incidence and difference in sex distribution of Achilles tendon rupture in Finland in 1987–1999. Scand J Surg. 2008;97(3):272–5.
Kannus P, Natri A. Etiology and pathophysiology of tendon ruptures in sports. Scand J Med Sci Sports. 1997;7(2):107–12.
Anders Nillius S, Nilsson BE, Westlin NE. The incidence of Achilles tendon rupture. Acta Orthop Scand. 47(1):118–21.
Davis JJ, Mason KT, Clark DA. Achilles tendon ruptures stratified by age, race, and cause of injury among active duty U.S. military members. Mil Med. 1999;164(12):872–3.
Parekh SG, Wray WH 3rd, Brimmo O, Sennett BJ, Wapner KL. Epidemiology and outcomes of Achilles tendon ruptures in the National Football League. Foot Ankle Spec. 2009;2(6):283–6.
Flik KR, Bush-Joseph CA, Bach BR Jr. Complete rupture of large tendons: risk factors, signs, and definitive treatment. Phys Sportsmed. 2005;33(8):19–28 + 47.
Kannus P, Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am. 1991;73(10):1507–25.
Komi PV, Fukashiro S, Jarvinen M. Biomechanical loading of Achilles tendon during normal locomotion. Clin Sports Med. 1992;11(3):521–31.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.
Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii-x, 1–173.
van Tulder M, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 2003;28(12):1290–9.
Magnusson SP, Qvortrup K, Larsen JO, Rosager S, Hanson P, Aagaard P, et al. Collagen fibril size and crimp morphology in ruptured and intact Achilles tendons. Matrix Biol. 2002;21(4):369–77.
Raleigh SM, Van Der Merwe L, Ribbans WJ, Smith RKW, Schwellnus MP, Collins M. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br J Sports Med. 2009;43(7):514–20.
Corrao G, Zambon A, Bertu L, Mauri A, Paleari V, Rossi C, et al. Evidence of tendinitis provoked by fluoroquinolone treatment a case-control study. Drug Saf. 2006;29(10):889–96.
Van der Linden PD, Sturkenboom MCJM, Herings RMC, Leufkens HMG, Rowlands S, Stricker BHC. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2003;163(15):1801–7.
Wise BL, Peloquin C, Choi H, Lane NE, Zhang Y. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med. 2012;125(12):1228.e3-.e.
Kettunen JA, Kujala UM, Kaprio J, Sarna S. Health of master track and field athletes: a 16-year follow-up study. Clin J Sport Med. 2006;16(2):142–8.
Posthumus M, September AV, Schwellnus MP, Collins M. Investigation of the Sp1-binding site polymorphism within the COL1A1 gene in participants with Achilles tendon injuries and controls. J Sci Med Sports. 2009;12(1):184–9.
Jozsa L, Kvist M, Balint BJ, Reffy A, Jarvinen M, Lehto M, et al. The role of recreational sport activity in Achilles tendon rupture. A clinical, pathoanatomical, and sociological study of 292 cases. Am J Sports Med. 1989;17(3):338–43.
Owens B, Mountcastle S, White D. Racial differences in tendon rupture incidence. Int J Sports Med. 2007;28(7):617–20.
Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006;15(11):784–92.
Vosseller JT, Ellis SJ, Levine DS, Kennedy JG, Elliott AJ, Deland JT, et al. Achilles tendon rupture in women. Foot Ankle Int. 2013;34(1):49–53.
Raikin SM, Garras DN, Krapchev PV. Achilles tendon injuries in a United States population. Foot Ankle Int. 2013;34(4):475–80.
Kraemer R, Wuerfel W, Lorenzen J, Busche M, Vogt PM, Knobloch K. Analysis of hereditary and medical risk factors in Achilles tendinopathy and Achilles tendon ruptures: a matched pair analysis. Arch Orthop Trauma Surg. 2012;132(6):847–53.
Maffulli N, Irwin AS, Kenward MG, Smith F, Porter RW. Achilles tendon rupture and sciatica: a possible correlation. Br J Sports Med. 1998;32(2):174–7.
Tallon C, Maffulli N, Ewen SWB. Ruptured Achilles tendons are significantly more degenerated than tendinopathic tendons. Med Sci Sports Exerc. 2001;33(12):1983–90.
Hansen P, Kovanen V, Holmich P, Krogsgaard M, Hansson P, Dahl M, et al. Micromechanical properties and collagen composition of ruptured human Achilles tendon. Am J Sports Med. 2013;41(2):437–43.
Maffulli N, Ewen SW, Waterston SW, Reaper J, Barrass V. Tenocytes from ruptured and tendinopathic Achilles tendons produce greater quantities of type III collagen than tenocytes from normal Achilles tendons. An in vitro model of human tendon healing. Am J Sports Med. 2000;28(4):499–505.
Jarvinen TAH, Jarvinen TLN, Kannus P, Jozsa L, Jarvinen M. Collagen fibres of the spontaneously ruptured human tendons display decreased thickness and crimp angle. J Orthop Res. 2004;22(6):1303–9.
Bleakney RR, Tallon C, Wong JK, Lim KP, Maffulli N. Long-term ultrasonographic features of the Achilles tendon after rupture. Clin J Sport Med. 2002;12(5):273–8.
Maffulli N, Barrass V, Ewen SW. Light microscopic histology of achilles tendon ruptures. A comparison with unruptured tendons. Am J Sports Med. 2000;28(6):857–63.
Leppilahti J, Korpelainen R, Karpakka J, Kvist M, Orava S. Ruptures of the Achilles tendon: relationship to inequality in length of legs and to patterns in the foot and ankle. Foot Ankle Int. 1998;19(10):683–7.
Jones GC, Corps AN, Pennington CJ, Clark IM, Edwards DR, Bradley MM, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum. 2006;54(3):832–42.
Petersen W, Pufe T, Zantop T, Tillmann B, Tsokos M, Mentlein R. Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendons. Clin Orthop Relat Res. 2004;420:286–91.
Legerlotz K, Jones ER, Screen HR, Riley GP. Increased expression of IL-6 family members in tendon pathology. Rheumatology (Oxford). 2012;51(7):1161–5.
Kujala UM, Jarvinen M, Natri A, Lehto M, Nelimarkka O, Hurme M, et al. ABO blood and musculoskeletal injuries. Injury. 1992;23(2):131–3.
Maffulli N, Reaper JA, Waterston SW, Ahya T. ABO blood groups and achilles tendon rupture in the Grampian Region of Scotland. Clin J Sport Med. 2000;10(4):269–71.
Raunest J, Burrig KF, Derra E. Pathogenesis of Achilles tendon rupture. Chirurg. 1990;61(11):815–9.
Kujala UM, Sarna S, Kaprio J. Cumulative incidence of achilles tendon rupture and tendinopathy in male former elite athletes. Clin J Sport Med. 2005;15(3):133–5.
Sode J, Obel N, Hallas J, Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol. 2007;63(5):499–503.
Parry DA, Craig AS. Collagen fibrils and elastic fibers in rat-tail tendon: an electron microscopic investigation. Biopolymers. 1978;17(4):843–5.
Parry DA, Barnes GR, Craig AS. A comparison of the size distribution of collagen fibrils in connective tissues as a function of age and a possible relation between fibril size distribution and mechanical properties. Proc R Soc Lond B Biol Sci. 1978;203(1152):305–21.
Nakagawa Y, Majima T, Nagashima K. Effect of ageing on ultrastructure of slow and fast skeletal muscle tendon in rabbit Achilles tendons. Acta Physiol Scand. 1994;152(3):307–13.
Longo UG, Ronga M, Maffulli N. Acute ruptures of the achilles tendon. Sports Med Arthrosc. 2009;17(2):127–38.
Shakibaei M, Pfister K, Schwabe R, Vormann J, Stahlmann R. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother. 2000;44(2):261–6.
Jorgensen C, Anaya JM, Didry C, Canovas F, Serre I, Baldet P, et al. [Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case] Arthropathies et tendinopathie achilleenne induites par la pefloxacine. A propos d’une observation. Rev Rhum Mal Osteoartic. 1991;58(9):623–5.
Movin T, Gad A, Guntner P, Foldhazy Z, Rolf C. Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Ankle Int. 1997;18(5):297–9.
Sendzik J, Shakibaei M, Schafer-Korting M, Stahlmann R. Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology. 2005;212(1):24–36.
Jarvinen TA, Kannus P, Paavola M, Jarvinen TL, Jozsa L, Jarvinen M. Achilles tendon injuries. Curr Opin Rheumatol. 2001;13(2):150–5.
Jones JG. Achilles tendon rupture following steroid injection. J Bone Joint Surg Am. 1985;67(1):170.
Smith M, Simpson NE. Report of the committee on the genetic constitution of 9 and 10. Cytogenet Cell Genet. 1989;51(1–4):202–25.
Samiric T, Ilic MZ, Handley CJ. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol. 2004;23(2):127–40.
Corps AN, Robinson AH, Movin T, Costa ML, Ireland DC, Hazleman BL, et al. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology (Oxford). 2004;43(8):969–72.
Scott A, Lian O, Bahr R, Hart DA, Duronio V. VEGF expression in patellar tendinopathy: a preliminary study. Clin Orthop Relat Res. 2008;466(7):1598–604.
Wang JH, Jia F, Yang G, Yang S, Campbell BH, Stone D, et al. Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connect Tissue Res. 2003;44(3–4):128–33.
Hui W, Bell M, Carroll G. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants. Cytokine. 1996;8(6):495–500.
Acknowledgment
The authors thank G.B. de Jonge and W. Bramer, medical librarians of the Erasmus Medical Center in Erasmus MC, for assistance in performing the literature search.
No sources of funding were used to assist in the preparation of this review. The authors have no potential conflicts of interest that are directly relevant to the content of this review.
Contributions
Femke Claessen, Duncan Meuffels, and Robert-Jan de Vos contributed to the conception and design of the study and to interpretation of the data. Femke Claessen drafted the article. Duncan Meuffels, Max Reijman and Robert-Jan de Vos revised the article for important intellectual comment. All authors gave final approval of the version to be submitted.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Claessen, F.M.A.P., de Vos, RJ., Reijman, M. et al. Predictors of Primary Achilles Tendon Ruptures. Sports Med 44, 1241–1259 (2014). https://doi.org/10.1007/s40279-014-0200-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40279-014-0200-z